Prosecution Insights
Last updated: October 04, 2026

Velico Medical Inc.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering

5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Analysis

Velico Medical Inc. is managing 5 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 5 distinct examiners, meaning each case has a unique reviewer. The workload is also distributed across 4 distinct art units, indicating that the company's biological innovations cover several different specialized classifications.

LAU, JASON is the busiest examiner for the portfolio, currently handling 1 pending office action. This is one of the 5 pending office actions for the company. With 5 distinct examiners and 4 distinct art units, the applicant must manage a variety of examiner preferences and art unit guidelines.

This distribution suggests a diverse range of technical challenges within the biotechnology sector. The presence of multiple distinct examiners ensures that each application receives an independent review. Strategy must be tailored to the specific requirements of 4 distinct art units to ensure broad protection across the entire portfolio. This approach allows for a more granular defense of the company's intellectual property. The applicant can focus on building a consistent body of evidence that satisfies the specific requirements of each administrative group.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

5
Total Pending OAs
1
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (20%)
3
Medium (60%)
1
Easy (20%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (40%)
§102 only1 (20%)
Double-patenting only1 (20%)
Multi-statute (no §101)1 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
60% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
20% of docket
1
Business / Other
20% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LAU, JASON 1 53.7% +15.6%
KOSAR, AARON J 1 71.2% +29.9%
VIJAYARAGHAVAN, JAGAMYA NMN 1 62.5% +49.3%
PILCHER, JONATHAN L 1 64.3% +44.0%
MARTIN, PAUL C 1 41.8% +21.6%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18467089 Blood Plasma Product VIJAYARAGHAVAN, JAGAMYA NMN 26d

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18791873 Alignment of A Disposable For A Spray Drying Plasma System LAU, JASON 43d overdue
17945126 Pretreatment Of Plasma For Spray Drying And Storage MARTIN, PAUL C 32d overdue
18467074 Pretreatment Of Plasma For Spray Drying And Storage PILCHER, JONATHAN L 16d
18467089 Blood Plasma Product VIJAYARAGHAVAN, JAGAMYA NMN 26d
18745283 Formulations And Methods For Contemporaneous Stabilization Of Active Proteins During Spray Drying And Storage KOSAR, AARON J —

Top Art Units

Art UnitApps
3762 1
1633 1
1772 1
1653 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18791873 Alignment of A Disposable For A Spray Drying Plasma System LAU, JASON 3762 §102Other Final Rejection 43d overdue Pending Aug 01, 2024
18745283 Formulations And Methods For Contemporaneous Stabilization Of Active Proteins During Spray Drying And Storage KOSAR, AARON J — DP Non-Final OA — Pending Jun 17, 2024
18467089 Blood Plasma Product VIJAYARAGHAVAN, JAGAMYA NMN 1633 §103§112Other Final Rejection 26d Pending Sep 14, 2023
18467074 Pretreatment Of Plasma For Spray Drying And Storage PILCHER, JONATHAN L 1772 §103 Final Rejection 16d Pending Sep 14, 2023
17945126 Pretreatment Of Plasma For Spray Drying And Storage MARTIN, PAUL C 1653 §103 Final Rejection 32d overdue Pending Sep 15, 2022

Managing Velico Medical Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month